Furthermore, the combination of sitagliptin tablets and Huangkui capsules has been shown to effectively reduce blood sugar, improve renal function, and lower the level of inflammatory factors, such as HMGB1, in early DN patients (121). The gene discussed is HMGB1; the disease is liver dysplastic nodule.